معرفی
Herbert Schiller is a Director of the Research Unit for Precision Regenerative Medicine (PRM) at Helmholtz Munich and a Professor for Systems Biology of the Airways and Lungs at the Medical Faculty of Ludwig Maximilian University (LMU) Munich. Previously, he served as Deputy Director of the Institute of Lung Health and Immunity (LHI) and held adjunct faculty positions at the Institute of Lung Health in Giessen, Germany.
- M.Sc. in Biology and Genetics (University of Vienna, 2004-2008)
- Ph.D. in Molecular Immunology (Medical University of Vienna, 2008)
- Postdoctoral training at Max Planck Institute of Biochemistry (2009-2015)
His research focuses on extending human healthspan by studying genetic and environmental drivers of chronic lung disease and aging through experimental systems biology and AI-driven approaches. Key areas include:
- Pulmonary systems biology
- Regenerative medicine and stem cell biology
- Extracellular matrix and mechanobiology
- Single-cell genomics
- Biology of aging and autoimmune diseases
His work emphasizes cross-disciplinary methods like human lung organotypic models and mass spectrometry proteomics. Research trends include lung fibrosis mechanisms, integrin-mediated mechanosensing, and AI applications in chronic disease modeling.
Scientific distinctions include:
- W2 Professorship at LMU Munich
- Dick Heinegard European Young Investigator Award
- Helmholtz Young Investigator award
- German Respiratory Society (DGP) research prize
- EMBO long term fellowship
He has secured research grants from the German Research Foundation (DFG), Chan Zuckerberg Initiative (CZI), and the European Commission. His lab employs cutting-edge single-cell RNA-seq, proteomics, and ex vivo tissue perturbation techniques to elucidate lung disease mechanisms.
